Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation. [electronic resource]
- Molecular cancer research : MCR 02 2017
- 141-151 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't